{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-289713","form_type":"8-K","ticker":"CUE","cik":"0001645460","company_name":"Cue Biopharma, Inc.","filed_at":"2025-11-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.029668+00:00","generated_at":"2026-05-16T17:59:41.125459+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cue Biopharma CMO Matteo Levisetti to depart Nov 28; gets $556,838 severance","bullets":["Chief Medical Officer Matteo Levisetti will terminate employment effective November 28, 2025.","Severance includes lump sum of $556,837.60 (nine months base salary plus prorated 2025 bonus).","COBRA premiums paid by company for up to nine months post-separation if elected.","Payment conditioned on execution and nonrevocation of a separation and release agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-289713","json":"https://secwatch.observer/filing/0001193125-25-289713.json","markdown":"https://secwatch.observer/filing/0001193125-25-289713.md","text":"https://secwatch.observer/filing/0001193125-25-289713.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1645460/000119312525289713/0001193125-25-289713-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1645460/000119312525289713/cue-20251117.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T17:59:41.125459+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}